Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Map Syndrome”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Not applicableStudy completedNCT01473498
What this trial is testing

Personalized Mean Arterial Pressure Management on Renal Function During Septic Shock

Who this might be right for
Septic ShockAcute Kidney Injury
Assistance Publique - Hôpitaux de Paris 27
Not applicableStudy completedNCT02198092
What this trial is testing

Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes

Who this might be right for
Familial Adenomatous PolyposisMap SyndromeLynch Syndrome+2 more
University of Pennsylvania 24
Testing effectiveness (Phase 2)Study completedNCT00113893
What this trial is testing

SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.

Who this might be right for
Bone Marrow DiseasesMyelodysplastic SyndromesHematologic Diseases+1 more
Scios, Inc. 62
Testing effectiveness (Phase 2)Study completedNCT01242462
What this trial is testing

Feasibility of Mid-frequency Ventilation in Newborns With RDS: Randomized Crossover Pilot Trial

Who this might be right for
Respiratory Distress Syndrome, Newborn
University of Alabama at Birmingham 12
Not applicableStudy completedNCT01752296
What this trial is testing

Psychological Concomitants of Morquio Syndrome (The MAP Study)

Who this might be right for
Morquio DiseaseMucopolysaccharidosis IV
Nadia Ali, PhD 20
Not applicableEnded earlyNCT03582046
What this trial is testing

Targeting Abdominal Perfusion Pressure in Septic Shock

Who this might be right for
Acute Kidney InjurySeptic ShockResuscitations
Potrero Medical 12
Not applicableStudy completedNCT03824366
What this trial is testing

Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy

Who this might be right for
MalignancyMetastasisHemoptysis+4 more
Washington University School of Medicine 20
Not applicableNo Longer AvailableNCT04498871
What this trial is testing

MAP to Provide Access to Nilotinib, for Patients With HES

Who this might be right for
Hypereosinophilic Syndrome (HES)
Novartis Pharmaceuticals
Not applicableAvailableNCT05028166
What this trial is testing

Individual Patient Compassionate Use of Mirdametinib

Who this might be right for
Neurofibromatosis Type 1-Associated Plexiform NeurofibromasHistiocytic NeoplasmOther MAP-K Pathway Driven Diseases
SpringWorks Therapeutics, Inc.
Not applicableStudy completedNCT02579525
What this trial is testing

Targeted Tissue Perfusion Versus Macrocirculatory-guided Standard Care in Patients With Septic Shock

Who this might be right for
Shock; SepticCritical Illness
Helsinki University Central Hospital 200
Not applicableAvailableNCT05222412
What this trial is testing

Managed Access Programs for LNP023, Iptacopan

Who this might be right for
C3 Glomerulopathy (C3G)Paroxysmal Nocturnal Hemoglobinuria (PNH)
Novartis Pharmaceuticals
Not applicableUnknownNCT04136080
What this trial is testing

The Effect of Increasing the Mean Arterial Pressure on the Microcirculation and the Prognosis of Patients With Septic Shock

Who this might be right for
Septic Shock
Fujian Provincial Hospital 752
Very early researchStudy completedNCT02789150
What this trial is testing

Outcomes of Renal Function in Hepatorenal Syndrome (HRS) Determined By Comparison of Target Mean Arterial Pressure (MAP) of 65 - 70 Mmhg Versus ≥ 85 Mmhg

Who this might be right for
Hepatorenal Syndrome
University of Louisville 18
Large-scale testing (Phase 3)Study completedNCT02145468
What this trial is testing

Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)

Who this might be right for
Acute Coronary Syndrome
GlaxoSmithKline 3,503
Large-scale testing (Phase 3)WithdrawnNCT02069288
What this trial is testing

Effects of Fludrocortisone on Norepinephrine-mean Arterial Pressure Dose-response in Septic Shock

Who this might be right for
Septic Shock
Rennes University Hospital
Not applicableStudy completedNCT04281277
What this trial is testing

Relation Between Mean Arterial Pressure and Renal Resistive Index in the Early Phase of Septic Shock

Who this might be right for
Septic Shock
University Hospital, Angers 80
Not applicableStudy completedNCT02453425
What this trial is testing

The Effects of Blood Pressure on Renal Function and Oxygenation in Septic Shock

Who this might be right for
Septic ShockAcute Kidney Injury
Sahlgrenska University Hospital 8
Not applicableStudy completedNCT00001642
What this trial is testing

Positional Cloning of the Gene(s) Responsible for Alagille Syndrome

Who this might be right for
Alagille Syndrome
National Human Genome Research Institute (NHGRI) 225
Post-approval studies (Phase 4)Study completedNCT02085291
What this trial is testing

Effect of Different Strategies for Titrating a High MAP on Microcirculation

Who this might be right for
Septic ShockHypertension
Southeast University, China 24
Not applicableStudy completedNCT05031819
What this trial is testing

Managing Hypertension Among People Living With HIV

Who this might be right for
Blood PressureHuman Immunodeficiency Virus I InfectionAcquired Immunodeficiency Syndrome+1 more
Dr. Dike Ojji 960
Load More Results